Zacks Research Has Negative Estimate for CLB FY2025 Earnings

Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research lowered their FY2025 EPS estimates for shares of Core Laboratories in a research report issued to clients and investors on Monday, June 16th. Zacks Research analyst R. Department now expects that the oil and gas company will earn $0.70 per share for the year, down from their previous estimate of $0.71. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories' Q3 2026 earnings at $0.19 EPS, Q4 2026 earnings at $0.27 EPS, FY2026 earnings at $0.83 EPS and Q1 2027 earnings at $0.21 EPS.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The business had revenue of $123.59 million during the quarter, compared to analysts' expectations of $125.09 million. During the same quarter in the previous year, the company posted $0.19 earnings per share. The company's quarterly revenue was down 4.7% compared to the same quarter last year.

Other analysts have also issued reports about the stock. Citigroup lowered their target price on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, May 13th. Wall Street Zen lowered shares of Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Finally, Stifel Nicolaus dropped their target price on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research note on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $15.00.

Core Laboratories Trading Down 1.2%

CLB stock traded down $0.16 during midday trading on Tuesday, reaching $12.42. The company's stock had a trading volume of 822,040 shares, compared to its average volume of 405,771. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21. The stock has a fifty day simple moving average of $11.75 and a two-hundred day simple moving average of $15.03. Core Laboratories has a 1 year low of $10.14 and a 1 year high of $25.13. The firm has a market capitalization of $582.39 million, a price-to-earnings ratio of 21.06, a PEG ratio of 3.87 and a beta of 1.40.

Institutional Trading of Core Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in CLB. Assetmark Inc. bought a new position in Core Laboratories during the 4th quarter worth about $26,000. Smartleaf Asset Management LLC lifted its position in shares of Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock worth $35,000 after purchasing an additional 1,293 shares during the period. AlphaQuest LLC boosted its stake in shares of Core Laboratories by 265,800.0% during the first quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company's stock valued at $40,000 after purchasing an additional 2,658 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in Core Laboratories by 843.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock valued at $57,000 after buying an additional 2,936 shares during the period. Finally, BNP Paribas Financial Markets purchased a new position in Core Laboratories during the fourth quarter valued at approximately $123,000. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, May 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.32%. Core Laboratories's dividend payout ratio is currently 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.